Compugen to Engage in Notable Conversations at H.C. Wainwright Investment Conference#New_York_City#Israel#Cancer_Immunotherapy#Investor_Relations#Compugen_Ltd
Compugen to Engage in Notable Conversations at H.C. Wainwright Investment Conference
Compugen Ltd. will join the H.C. Wainwright 28th Annual Global Investment Conference, featuring a fireside chat and one-on-one meetings in New York City.
third-news.com
September 8, 2026 at 11:16 AM
Compugen to Engage in Notable Conversations at H.C. Wainwright Investment Conference#New_York_City#Israel#Cancer_Immunotherapy#Investor_Relations#Compugen_Ltd
Compugen to Showcase Innovations at the Upcoming BTIG Biotechnology Conference 2026#Israel#Cancer_Immunotherapy#Holon#Compugen_Ltd#Biotechnology_Conference
Compugen to Showcase Innovations at the Upcoming BTIG Biotechnology Conference 2026
Compugen Ltd. is set to participate in the virtual BTIG Biotechnology Conference 2026, showcasing their advancements in cancer immunotherapy and computational discovery.
third-news.com
July 21, 2026 at 11:15 AM
Compugen to Showcase Innovations at the Upcoming BTIG Biotechnology Conference 2026#Israel#Cancer_Immunotherapy#Holon#Compugen_Ltd#Biotechnology_Conference
Compugen Set to Showcase Innovations in Cancer Immunotherapy at Upcoming Investor Conferences#Israel#Cancer_Immunotherapy#Holon#AI_Powered#Compugen_Ltd
Compugen Set to Showcase Innovations in Cancer Immunotherapy at Upcoming Investor Conferences
Compugen Ltd. confirms participation in vital investor conferences, focusing on advanced immunotherapy and AI-driven biopharma solutions. Stay tuned for updates.
third-news.com
February 19, 2026 at 12:16 PM
Compugen Set to Showcase Innovations in Cancer Immunotherapy at Upcoming Investor Conferences#Israel#Cancer_Immunotherapy#Holon#AI_Powered#Compugen_Ltd